62.80
+0.48%
Close of 9 Nov 2026, in SEK
Search any instrument
Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.
About Paxman AB (publ)
Its shares trade on Nasdaq Stockholm under the ticker PAX.ST. It has been listed since 12 June 2017. In the fiscal year to 31 December 2025, it reported revenue of SEK 313.3m and a net loss of SEK 16.7m. At that date it held total assets of SEK 479.1m and shareholders' equity of SEK 405.2m.
Paxman AB engages in the research and development of scalp cooling system. The company is headquartered in Karlshamn, Blekinge. The company went IPO on 2017-06-12. The cooling system aims to reduce the risk of hair loss connected with cytostatic treatment of cancer. The firm offers a stand-alone, mobile electric cooling unit, which markets under the name Paxman Scalp Cooler, which is a liquid-based cooling system that cools down the patients scalp through the silicone hat. The product has two versions - for one or two patients to be cooled at once. Each device contains a built-in touch screen with a menu-controlled graphic user interface to monitor the process. The lightweight system enables patient to participate in other activities. The Company’s primary markets are Great Britain, Scandinavian countries, the Netherlands, Belgium and Australia.
Figures and description from our data supplier, not checked against the company's own report.
Company facts
- Sector
- Health Care
- Industry
- Health Care Equipment & Supplies
- Listed since
- 12 Jun 2017
- Employees
- 52
- Website
- paxman.se ↗
Leadership
Pay as last reported
- Mr. Per-Anders JohanssonChairman of the Board
- Mr. Richard PaxmanChief Executive Officer, Director, since 2017
- Ms. Emelie GustafssonChief Financial Officer
- Mr. Glenn PaxmanDirector
- Ms. Maria BechIndependent Director
- Ms. Karen ClakeleyIndependent Director
- Mr. Robert KellyIndependent Director
- Mr. Bjoern LittorinIndependent Director
Environmental, social and governance
Scores out of 100, from our data supplier
- Overall
- 6
- Environment
- 2
- Social
- 10
- Governance
- 6
- Carbon reduction policy
- No
- Human rights policy
- No
SWOT analysis
AI-generated by our data supplier. Not written or checked by our editors.
Strengths
- Strong market presence: Paxman AB (publ) has established a strong market presence in its industry, allowing it to leverage its brand reputation and customer base to drive growth and maintain a competitive advantage.
- Innovative product portfolio: The company offers a diverse range of innovative products that cater to various customer segments. This enables Paxman AB (publ) to meet the evolving needs of its target market and stay ahead of competitors.
- Robust distribution network: Paxman AB (publ) has built a robust distribution network, encompassing both domestic and international markets. This extensive reach ensures efficient supply chain management and broad market penetration.
Weaknesses
- Limited global presence: Despite its strong position in its core markets, Paxman AB (publ) has limited global presence compared to some of its competitors. This can potentially hinder its growth and expansion opportunities in untapped regions.
- Dependency on key suppliers: The company relies on a few key suppliers for critical components or materials. Any disruption in the supply chain could adversely impact production and product availability.
- Relatively higher pricing: Paxman AB (publ)'s products may be priced at a premium compared to some alternatives in the market. This could limit the company's ability to attract price-sensitive customers, especially in cost-conscious regions.
Opportunities
- Growing demand for innovative medical devices: The global healthcare industry is witnessing an increasing demand for advanced medical devices. This presents an opportunity for Paxman AB (publ) to capitalize on its innovative product portfolio and expand its market share.
- Expansion into emerging markets: Emerging markets offer untapped growth potential for Paxman AB (publ). By strategically entering these markets, the company can tap into new customer segments and gain a competitive edge.
- Partnerships and collaborations: Collaborating with healthcare providers, researchers, and other industry players can facilitate the development of new treatments and enhance the company's product offerings. These partnerships can also open doors to new market opportunities.
Threats
- Intense competition: The medical device industry is highly competitive, with numerous players vying for market share. Paxman AB (publ) faces the threat of intense competition, which may require continuous innovation and competitive pricing strategies to maintain its position.
- Regulatory challenges: Compliance with evolving regulations and standards in the healthcare industry can pose challenges and introduce additional costs. Paxman AB (publ) needs to ensure strict adherence to regulations and invest in product certifications to mitigate potential risks.
- Technological advancements: Rapid technological advancements can disrupt the medical device industry. Paxman AB (publ) must stay at the forefront of emerging technologies to remain relevant and avoid being outpaced by more innovative competitors.
Sources and methodology
- Data on this tab
- Our data supplier
- Chart on the Overview
- TradingView
Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.